VIRO.CO Stock - ViroGates A/S
Unlock GoAI Insights for VIRO.CO
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $4.90M | $6.99M | $15.20M | $7.66M | $5.35M |
| Gross Profit | $2.56M | $5.80M | $12.66M | $5.79M | $4.19M |
| Gross Margin | 52.4% | 83.1% | 83.3% | 75.6% | 78.3% |
| Operating Income | $-16,805,000 | $-12,565,000 | $-10,845,000 | $-18,789,000 | $-19,729,000 |
| Net Income | $-14,345,000 | $-12,096,000 | $-9,646,000 | $-17,663,000 | $-18,736,000 |
| Net Margin | -292.9% | -173.1% | -63.5% | -230.7% | -349.9% |
| EPS | $-2.15 | $-3.49 | $-2.29 | $-4.32 | $-4.69 |
ViroGates A/S develops and markets prognostic products for the healthcare sector. It offers suPARnostic, a blood test that measures the soluble urokinase plasminogen activator receptor (suPAR) protein in the bloodstream used for emergency departments in hospitals to improve clinical decisions on hospitalization or discharge of acute medical patients and reduce healthcare cost. The company also provides suPARnostic TurbiLatex, a latex particle-enhanced turbidimetric immunoassay that quantitatively determines the suPAR level in human K2-EDTA- or lithium heparin plasma samples; suPARnostic Quick Triage kit, which is used in the point of care situation for early warning and patient triaging; and suPARnostic ELISA that provides fully quantitative results. Its suPAR prognostic tool used in various diseases, such as cardiovascular, kidney, cancer, diabetes, liver, infectious, respiratory, and rheumatic. The company was incorporated in 2000 and is headquartered in Birkerød, Denmark.
Visit WebsiteEarnings History & Surprises
VIRO.COEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2025 | Mar 31, 2025 | — | $-0.42 | — | — |
Q4 2024 | Dec 31, 2024 | — | $-0.57 | — | — |
Q3 2024 | Sep 30, 2024 | — | $-0.35 | — | — |
Q2 2024 | Jun 29, 2024 | — | $-0.64 | — | — |
Q2 2024 | Apr 26, 2024 | — | $-0.56 | — | — |
Q4 2023 | Dec 30, 2023 | — | $-0.51 | — | — |
Q3 2023 | Sep 30, 2023 | — | $-0.49 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.85 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.68 | — | — |
Q4 2022 | Dec 31, 2022 | $-0.56 | $-0.41 | +26.1% | ✓ BEAT |
Q3 2022 | Sep 30, 2022 | $-0.80 | $-0.89 | -10.7% | ✗ MISS |
Q2 2022 | Jun 30, 2022 | $-0.87 | $-0.61 | +30.1% | ✓ BEAT |
Q1 2022 | Mar 31, 2022 | $-0.66 | $-0.94 | -42.9% | ✗ MISS |
Q4 2021 | Dec 31, 2021 | — | $-1.27 | — | — |
Q3 2021 | Sep 30, 2021 | $-1.03 | $-1.38 | -34.9% | ✗ MISS |
Q2 2021 | Jun 30, 2021 | — | $-1.62 | — | — |
Q2 2021 | Apr 29, 2021 | — | $-1.42 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-1.41 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-1.20 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-1.40 | — | — |
Latest News
Frequently Asked Questions about VIRO.CO
What is VIRO.CO's current stock price?
What is the analyst price target for VIRO.CO?
What sector is ViroGates A/S in?
What is VIRO.CO's market cap?
Does VIRO.CO pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to VIRO.CO for comparison